From the Journals

Nurses or physicians: Who are at highest suicide risk?


 

Benchmark research

Commenting on the study, Constance Guille, MD, MSCR, professor in the department of psychiatry and behavioral science, Medical University of South Carolina, Charleston, noted that nurses are “predominantly female” and that women tend to be twice as likely as men to experience depression, which is a major risk factor for suicide. Thus, this population is particularly vulnerable.

One reason the investigators did not find that suicide rates were higher among physicians is that the health care professionals whom the researchers studied were older than 30 years. Thus, the study “excludes younger physicians in early practice or training, who likely do have higher suicide rates than the general population,” she suggested.

Dr. Guille, who is the author of an accompanying editorial and was not involved with the study, recommended “taking a public health approach, implementing preventative interventions, identifying people at high risk, providing treatment for health care professionals struggling with mental health problems, and destigmatizing help seeking.”

She encouraged clinicians to “reach out to colleagues who are struggling in a way to help them seek services and check in with them because it’s helpful when peers reach out.”

Dr. Davis noted that these disturbing trends will likely increase in the aftermath of the COVID-19 pandemic. “The pandemic has placed enormous strain on the health care workforce, and we fear this may have made the situation even worse.”

The current findings “will serve as a benchmark for future comparisons,” he said.

No source of funding for the study was reported. Dr. Davis has received consulting fees as a statistical reviewer for the journal Regional Anesthesia and Pain Medicine. His coauthors disclosed no relevant financial relationships. Dr. Guille has received grants from the National Institute on Drug Abuse, the American Foundation on Suicide Prevention, and the Duke Endowment and serves on the advisory board and speakers bureau of Sage Therapeutics.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Antidepressants, TMS, and the risk of affective switch in bipolar depression
MDedge Psychiatry
Steroid-induced psychiatric symptoms: What you need to know
MDedge Psychiatry
Borderline personality disorder diagnosis: To tell or not to tell patients?
MDedge Psychiatry
An international trip: Global experts weigh in on psychedelics
MDedge Psychiatry
Contradictions abound in ‘The End of Mental Illness’
MDedge Psychiatry
How physicians can provide better care to transgender patients
MDedge Psychiatry
Adult separation anxiety raises suicidality risk
MDedge Psychiatry
Shedding the super doctor myth
MDedge Psychiatry
Helping psychiatric patients heal holistically
MDedge Psychiatry
Psilocybin matches SSRI for moderate to severe depression in phase 2 study
MDedge Psychiatry